← Back to Search

MuST AKT Program for Kidney Transplant (MuST AKT Trial)

N/A

Waitlist Available

Led By Dr. Shojai

Research Sponsored by University of Alberta

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up from start date to end date of study recruitment, up to 1 year

Awards & highlights

No Placebo-Only Group

Summary

This trial will help researchers understand if the intervention they've developed is effective in helping people with kidney failure find living donors, which could potentially improve patient outcomes and reduce healthcare costs.

Who is the study for?

This trial is for English-speaking individuals with kidney failure who have completed a 'kidney transplant introduction' module and are eligible for a transplant. It's not open to those who already have a donor, have had previous transplants, need multiple organ transplants, or score low on certain psychosocial or literacy tests.

What is being tested?

The MuST AKT intervention is being tested to help patients find living kidney donors through their social networks. The goal is to increase the number of living donor kidney transplants in Alberta by providing personalized support from a multidisciplinary team.

What are the potential side effects?

Since this trial involves an educational and support intervention rather than medication, traditional side effects are not applicable. However, participants may experience emotional or psychological impacts as they engage with their social networks.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ from start date to end date of study recruitment, up to 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~from start date to end date of study recruitment, up to 1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and from start date to end date of study recruitment, up to 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Living Kidney Donor Transplantation

Secondary study objectives

Contact Living Donor Services

Living Kidney Donor Evaluation Approved

Living Kidney Donor Evaluation Started

Other study objectives

Consent rate

Contact Living Donor Services (numbers)

Conversation started

+17 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

This arm will receive the MuST AKT intervention, which is a multidisciplinary, tailored person-centered behavioural intervention designed to "help and enable" the potential kidney transplant recipients to achieve what is required to receive a living donor kidney transplantation.

Group II: Usual Care (control)Active Control1 Intervention

In the usual care (control) condition, participants will go through the current standard of care, which is a social worker assessment.

Do I qualify?Apply below to find out